The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability
Abstract
To reduce the side effects of corticosteroid treatment, the administered dose of glucocorticoids (GCs) should be kept to a minimum while preserving therapeutically needed intracellular levels. Currently available assays to determine individual sensitivity to GCs are either imprecise or based on inhibition by GCs of lymphocyte proliferation following stimulation with phytohemagglutinin or other mitogens, which may influence the GC signal transduction pathway. Using the human lymphoblastoid cell line IM-9 as a model system, we studied whether the GC-induced increase of the mRNA encoding the 51-kDa FK506-binding protein (FKBP51) could be used for the development of a novel assay, ultimately to be used in native human peripheral blood mononuclear cells (PBMCs). GC addition to IM-9 cells resulted in a dose-dependent increase of FKBP51 mRNA levels within 2 h, followed by a further increase until 24 h. Northern blot analysis and real-time PCR yielded similar results. Coincubation of GCs with the GC receptor antagonist ORG 34116 or the protein synthesis inhibitor cycloheximide suggested a direct, GC receptor-mediated up-regulation of FKBP51 gene transcription. Expected differences in potency among different GCs could be readily demonstrated in this system. Extending our observations in IM-9 lymphoblasts to normal PBMCs, we found a dose-dependent increase of FKBP51 mRNA on ex vivo incubation of native human PBMCs with GCs, with a sensitivity of about 10(-9) M for dexamethasone. Moreover, dexamethasone ingestion increased FKBP51 mRNA in PBMCs in vivo, extending the use of this assay to the measurement of GC bioavailability. Finally, using this method we were able to demonstrate partial GC-insensitivity in a 6-month-old infant suffering from congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. We conclude that the induction of FKBP51 mRNA by GCs may be a suitable marker to assess individual GC sensitivity, the in vitro measurement of GC potency, and the in vivo determination of GC bioavailability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of FKBP5 is induced by glucocorticoids, thus forming an ultrashort intracellular negative-feedback loop for GR activity in response to stressor exposure (Vermeer et al, 2003)”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 induction by GR activation has been proposed as a molecular indicator of GR sensitivity (Ja ¨a ¨skela ¨inen et al, 2011;Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 is a heatshock protein 90 associated cochaperone of the GR and its expression is strongly induced by glucocorticoids via intronic steroid response elements as part of an intracellular short negative feedback loop for GR activity (Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
Citations
Cites
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00526-3 · Cited by 1,179
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892 · cited 1×
“This number was used to relate the initial quantity of cDNA of interest in each sample to one another (21).”
MethodTranscriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388
Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.
Rosewicz, S., McDonald, A. R., Maddux, B. A., Goldfine, I. D., Miesfeld, R. L., & Logsdon, C. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69104-5 · Cited by 322 · cited 1×
“On the other hand, it has been reported that GCs induce downregulation of GC receptor mRNA itself in IM-9 cells (41).”
BackgroundThe human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
Güssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., & Ploegh, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3132 · Cited by 319 · cited 1×
“Primers used were 5 -AAAAGGCCAAGGAGCACAAC-3 and 5 -TTGAGGAGGGGCCGAGTTC-3 for the FKBP51 PCR (TIB-Molbiol, Berlin, Germany) and 5 -CCAGCAGAGAATGGAAAGTC-3 and 5 -GATGCTGCTTACATGTCTCG-3 for the 2-microglobulin ( 2m) PCR (20).”
MethodHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265 · cited 1×
“polymorphisms of the GC receptor (10, 11) and the avail-”
BackgroundSyndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235 · cited 1×
“Partial insensitivity to glucocorticoids can be caused by several mechanisms and has been described in many other patients (42).”
BackgroundNair, S. C., Rimerman, R. A., Toran, E. J., Chen, S., Prapapanich, V., Butts, R. N., & Smith, D. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.594 · Cited by 196 · cited 1×
“The immunophilin FKBP51 forms part of the Hsp90 steroid receptor complex (38) and has been shown to reduce the affinity of both the squirrel monkey and human GC receptor for its ligand when overexpressed (39, 40).”
Background
Cited by
Machines and Mindlessness: Social Responses to Computers
Nass, C., & Moon, Y. (2000) · Journal of Social Issues · doi:10.1111/0022-4537.00153 · Cited by 4,022
Binder, E. B. (2008) · JAMA · doi:10.1001/jama.299.11.1291 · Cited by 1,362
“FKBP5 expression is induced by glucocorticoids as part of an intracellular ultrashort negative feedback loop for GR activity.(53) Overexpression of human FKBP5 in vitro reduces hormone binding affinity(54) and nuclear translocation of GR.”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
“Another interesting feature of FKBP5 is that its expression is induced by steroids, including glucocorticoids as part of an intracellular ultra-short negative feedback loop for GR activity (Vermeer et al., 2003).”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Metadata
- Authors
- Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M.
- Affiliations
- University Medical Center Utrecht (NL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-01
- Volume
- 88
- Issue
- 1
- Pages
- 277-284
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087836842
- Cited by
- 285
- References
- 40
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 18 · 2019: 19 · 2018: 12 · 2017: 15 · 2016: 18 · 2015: 18 · 2014: 15 · 2013: 11 · 2012: 17
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoids, FKBP51, FKBP, glucocorticoid receptor, gene transcription, lymphocytes, peripheral blood mononuclear cells, glucocorticoid sensitivity, glucocorticoid potency, dexamethasone, congenital adrenal hyperplasia, 21-hydroxylase deficiency, cycloheximide
- MeSH terms
- Tacrolimus Binding Protein 5, Biological Availability, Computer Systems, Dexamethasone, Drug Resistance, Female, Glucocorticoids, Humans, Infant, Lymphocytes, Receptors, Glucocorticoid, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Blotting, Northern, Biomarkers, Polymerase Chain Reaction, Tacrolimus Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability. https://app.cochat.ai/papers/10.1210/jc.2002-020354
- The paper
- Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M. (2003). Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2002-020354
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.